Form 4: MediWound Director Reports Stock Transaction
Insider Transaction (Form 4)
Samuel Rubinstein, a Director of MediWound Ltd., reported multiple transactions in common stock on September 1, 2026.
Summary
- Open-market sale: disposed of 525 Ordinary Shares at $12.72 ($6,678) on September 1, 2026 (Indirect).
- Open-market purchase: acquired 525 Ordinary Shares at $12.62 ($6,626) on September 1, 2026; holds 525 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai notes net insider selling of $52 across mixed open-market transactions.
Insider Transactions
Samuel Rubinstein — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Open-market sale | Ordinary Shares | 525 | $13 | $6.7K | 0 |
| 2026-09-01 | Open-market purchase | Ordinary Shares | 525 | $13 | $6.6K | 525 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Open-market sale (525 shares) |
| 2026-09-01 | Open-market purchase (525 shares) |
Keywords
insider transaction, Form 4, MDWD, MediWound Ltd., net selling, Samuel Rubinstein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.